SCHEMBL4197657

SCHEMBL4197657

C[C@@H](CC1CCCC1)NCc1ccccc1NS(=O)(=O)c1ccc2nc(N)sc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.44
LMNA P02545 4/20 0.44
PKM P14618 3/20 0.44
MAPT P10636 4/20 0.42
HSD17B10 Q99714 2/20 0.42
HTT P42858 2/20 0.42
USP2 O75604 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CYP2D6 P10635 2/20 0.41
KDM4E B2RXH2 2/20 0.41
HPGD P15428 3/20 0.40
KMT2A Q03164 1/20 0.40
VDR P11473 1/20 0.39
GFER P55789 1/20 0.39
GPR55 Q9Y2T6 1/20 0.39
CYP3A4 P08684 2/20 0.38
CYP2C9 P11712 1/20 0.38
HSP90AA1 P07900 1/20 0.38
TSHR P16473 1/20 0.38
AKT1 P31749 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4186018 0.99 ALDH1A1 (0.43) ALDH1A1LMNAPKMMAPTHSD17B10
SCHEMBL4194631 0.97 ALDH1A1 (0.46) ALDH1A1LMNAPKMMAPTHSD17B10
SCHEMBL4192953 0.92 MAPT (0.47) ALDH1A1LMNAPKMMAPTHSD17B10
SCHEMBL4194915 0.90 ALDH1A1 (0.44) ALDH1A1LMNAPKMMAPTHTT
SCHEMBL4190737 0.89 ALDH1A1 (0.43) ALDH1A1LMNAPKMMAPTHTT
SCHEMBL4200050 0.88 ALDH1A1 (0.41) ALDH1A1LMNAPKMMAPTHSD17B10
SCHEMBL4193911 0.88 ALDH1A1 (0.43) ALDH1A1LMNAPKMMAPTHTT
SCHEMBL14344005 0.86 ALDH1A1 (0.44) ALDH1A1LMNAPKMMAPTHSD17B10
SCHEMBL4192343 0.86 ALDH1A1 (0.47) ALDH1A1LMNAPKMHSD17B10HTT
SCHEMBL4192945 0.86 ALDH1A1 (0.48) ALDH1A1LMNAPKMMAPTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed
EP-1879877-A2 ANTIMICROBIAL AGENTS Ranbaxy Laboratories Limited (IN) 2008-01-23 EP disclosed
WO-2006117762-A2 ANTIMICROBIAL AGENTS RANBAXY LABORATORIES LIMITED (IN) 2006-11-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 ALDH1A1 2744/4885LMNA 2332/4885PKM 1855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.